Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) — Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and multiple scientific presentations at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting being held April 25-28, 2025 in Los Angeles, California.
These presentations will showcase the company’s latest clinical advancements and novel research in laser scleral microporation – a minimally invasive treatment designed to restore natural Dynamic Range of Focus (DRoF) in presbyopic patients. The company’s participation highlights its continued leadership in the development of non-lens-based solutions for aging-related vision loss.
Explore More Articles
New-generation software further improves precision of laser scleral microporation
VIENNA — In this Healio Video Perspective from the ESCRS meeting, Luca Gualdi, MD, speaks about the latest advances in laser scleral microporation. Laser scleral microporation (LSM, Ace Vision Group) is a treatment that restores accommodation in presbyopic patients by uncross-linking the scleral tissue that becomes stiff with age. It does so by performing arrays of micropores in …
read moreDynamic Range of Focus of the Eye: Understanding Biomechanics and Kinematics: Part II
IN PART I OF THIS 3-PART series, we outlined the definition of ocular biomechanics and kinematics and described the mechanical laws under which they operate.1 In this article, we describe the specific elements and motions responsible for achieving Dynamic Range of Focus (DRoF), including the phases of vision from accommodation to disaccommodation (near to far) and disaccommodation …
read moreVESA prediction tool could help guide presbyopia treatment
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, AnnMarie Hipsley, DPT, PhD, founder and CEO of Ace Vision Group, speaks about the Virtual Eye Simulation Analyzer, a device with predictive diagnostic capabilities. VESA uses ray tracing technology to analyze lens changes and biomechanics related to accommodation and disaccommodation, visualizing them in virtual reality and predicting …
read more